Preventing Drug Errors Related to Caregiver Interruptions

Status Completed

Clinical Trial Summary

Serious medication administration errors are common in hospitals and nurse's interruptions during medication preparation and administration is associated with errors. Various interventions were developed to help prevention of errors such as visual intervention. Investigators aimed to study the effect of a medication safety vest to reduce medication errors. The vest serves as a visible signal to inform others that the nurse is preparing and administering medications and should not be disturbed. Patients and visitors are provided with an informational flyer to inform them about the use of medication safety vests. The hypothesis is that the vest will reduce nurse's interruptions during medication preparation and administration, and ultimately reduce medication errors. The study is a randomized controlled trial in 30 care units of four hospitals in France. Each unit will be randomized in either the control group or the experimental group using the medication safety vest. Nurses of the unit will be selected at random to determine who will be observed during the administration rounds.The observation method will be used to evaluate the error rates in the 2 groups. The number of interruptions and error rates will be evaluated.

Clinical Trial Description

Serious medication administration errors are common in hospitals. Significant association between medication administration errors rate and the frequency of nurse's interruptions was shown. The estimated risk of error without interruption during preparation and administration is 2.3% whereas it doubles with 4 or more interruptions. Various interventions were developed to help prevention of errors such as visual interventions and technology interventions. Investigators aimed to study the effect of a medication safety vest to reduce medication errors. The vest serves as a visible signal to inform others that the nurse is preparing and administering medications and should not be disturbed. On the back of the vest is written "Do not disturb me. I am preparing medications". Patients and visitors are provided with an informational flyer to inform them about the use of medication safety vests The hypothesis is that the vest will reduce nurse's interruptions during medication preparation and administration, and ultimately reduce medication errors. The study is a randomized controlled trial in 30 care units of four hospitals in France. Each unit will be randomized in either the control group or the experimental group using the medication safety vest. Nurses of the unit will be randomized to determine who will be observed during the administration rounds.The observation method will be used to evaluate the error rates in the 2 groups. The number of interruptions and error rates will be evaluated. ;

Study Design

Related Conditions & MeSH terms

Medication Administered in Error

Clinical Trial Details

NCT number	NCT03062852
Study type	Interventional
Source	Assistance Publique - Hôpitaux de Paris
Contact
Status	Completed
Phase	N/A
Start date	March 15, 2017
Completion date	April 17, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03219151` - Evaluation of a Gamified Electronic Medication Administration Record (eMAR) System	N/A
Withdrawn	`NCT02325336` - Detection Medication Administration Errors Using Bar-code and RFID Technology (DREAM)	N/A
Completed	`NCT02228694` - The IMPROVE Study-IMPact of a Regulated ADC System	N/A
Recruiting	`NCT05761847` - Pediatric Medication Therapy Management Trial	N/A
Completed	`NCT02598609` - SEPREVEN: a Stepped-wedge Randomised Controlled Trial	N/A
Completed	`NCT04668248` - Novel Application of Simulation for Providers to Overcome Decisional Gaps in High-risk Prescribing	N/A
Completed	`NCT01337063` - Multi-Center Medication Reconciliation Quality Improvement Study	N/A
Completed	`NCT03181906` - Effectiveness of Pre-Consultation Medication Reconciliation Service in Reducing Unintentional Medication Discrepancies During Transition of Care From Hospital Discharge to Primary Care Setting	N/A
Recruiting	`NCT04278690` - Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit	N/A
Completed	`NCT00545155` - Screening and Interventions in an Acute Care Setting	N/A
Recruiting	`NCT01906710` - the Pharmacy Intervention Team Hospital-based (PITH) for People Study: Effect on Clinical and Economic Outcomes	N/A
Not yet recruiting	`NCT05476705` - Identifying Drug-related Problems at ED Triage (DRP-EDiT) V1
Completed	`NCT02359734` - A National Study of Intravenous Medication Errors	N/A
Active, not recruiting	`NCT00740675` - Ambulatory Medication Reconciliation Following Hospital Discharge	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Preventing Drug Errors Related to Caregiver Interruptions — PERMIS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms